Startup India Government of India
Difgen Pharmaceuticals Private Limited - research & development in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹76.63 Cr
▲ 84% YoY
Net profit · FY 2025
₹7.52 Cr
Net margin 9.8%
EBITDA · FY 2025
₹12.74 Cr
EBITDA margin 16.6%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
₹50.95 Lakh
Secured borrowings
Company age
4 yrs
Est. 2022
Employees · EPFO
92
Provident fund records
About Difgen Pharmaceuticals Private Limited
Data last updated:
Difgen Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Difgen Pharmaceuticals Llc and recognised as a startup by DPIIT. It operates in the research and development sector. It was incorporated on 06 May 2022.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U72100TG2022PTC162383. Its GSTIN is 36AAJCD2630H1ZT (Telangana).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Krishna Chandrasekaran and Zubin Keki Gandhi.
Its last annual general meeting (AGM) was held on 11 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹76.63 Cr, a growth of 84% compared to the previous year. For the same year it recorded a net profit of ₹7.52 Cr (net margin 9.8%) and EBITDA of ₹12.74 Cr (EBITDA margin 16.6%).
The company has about 92 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹50.95 Lakh on record. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹99 Lakh; the latest was in July 2022.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website difgen.com.
Company details
CIN U72100TG2022PTC162383
Registration Number 162383
Incorporation Date 06 May 2022
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 11 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Difgen Pharmaceuticals Llc
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
CIN history
Difgen Pharmaceuticals has one previous CIN (Corporate Identification Number): U24230TG2022PTC162383. The current CIN is U72100TG2022PTC162383, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U72100TG2022PTC162383 | Current |
| U24230TG2022PTC162383 | Previous |
Key People
Valiveti Brahmaji Additional Director Krishna Chandrasekaran Director Zubin Keki Gandhi Director Recognitions & Rankings of Difgen Pharmaceuticals
Contact details
Difgen Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is difgen.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address5 – 35/189A Survey No. 390 Prashanthi Nagar, 100 Feet Road Ie Kukatpally Rangareddy, Hyderabad, Telangana, India – 500072
- IndustryResearch & Development, Research & Development
To see the full contact details of Difgen Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Difgen Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Difgen Pharmaceuticals is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Difgen Pharmaceuticals Private Limited, buy the company report.
Financials of Difgen Pharmaceuticals Private Limited
FY 2025 filings availableDifgen Pharmaceuticals Private Limited reported revenue of ₹76.63 Cr (up 84% YoY) for FY 2025.
Revenue · FY 2025
₹76.63 Cr ▲ 84%
Net profit · FY 2025
₹7.52 Cr margin 9.8%
EBITDA · FY 2025
₹12.74 Cr margin 16.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 84%
EBITDA CAGR growth
1 year
▲ 456%
Revenue rose 84% in the latest year. EBITDA rose 456% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹12.74 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹7.52 Cr | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 16.6% | ||
| Net Profit Margin | 9.8% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Difgen Pharmaceuticals Private Limited, buy the company report.
Board of directors of Difgen Pharmaceuticals Private Limited
Difgen Pharmaceuticals has 11 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Valiveti Brahmaji Also directs: Riconpharma India Private Limited, Prathyak Laboratories Private Limited, Vivint Pharma Private Limited and 2 more | Additional Director | 21 Jan 2025 | 1 Years 9 Months | Current |
| Krishna Chandrasekaran | Director | 24 Jul 2023 | 3 Years 3 Months | Current |
| Zubin Keki Gandhi Also directs: Orizo Pharma Private Limited, Venus Ethoxyethers Pvt Ltd, Grand Organics Private Limited and 4 more | Director | 24 May 2022 | 4 Years 5 Months | Current |
| Yatin Kirtanlal Desai Also directs: Orizo Pharma Private Limited | Director | 24 May 2022 | 4 Years 5 Months | Current |
| Punit Chunilal Thakrar Also directs: Orizo Pharma Private Limited, Polydrug Laboratories LLP | Director | 04 Jul 2022 | 4 Years 4 Months | Current |
| Santhanakrishnan Srinivasan | Director | 15 Nov 2022 | 3 Years 11 Months | Current |
Showing 6 of 11 current directors. View all directors
Auditor
Difgen Pharmaceuticals Private Limited is audited by B Y & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B Y & ASSOCIATES | FY 2024 | 123423W |
Shareholding
The shareholding of Difgen Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Difgen Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹50.95 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 May 2024 | 100937260 | Hdfc Bank Limited | ₹26.87 Lakh | Open | |
| 25 Jul 2022 | 100602835 | Hdfc Bank Limited | ₹24.08 Lakh | Open |
Total charge records: 2 View all charges
Deals & funding
Difgen Pharmaceuticals Private Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹99 Lakh; the latest was in July 2022.
Total deals
2
Funding round
1
Secondary share transfer
1
Disclosed funding
₹99 Lakh
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jul 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jun 2022 | Funding round | ₹99 Lakh | Investors: DifGen Pharmaceuticals LLC, 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Difgen Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Difgen Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Difgen Pharmaceuticals Private Limited has a workforce of 92 employees on its EPFO records as of Mar 24, 2025, across 1 active EPFO establishment.
Employee count
92
Active EPFO establishments
1
Employee growth
124.39%
GST
Difgen Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAJCD2630H1ZT | Telangana | Active | 13 Jun 2022 |
To see the full GST registrations and return filing status of Difgen Pharmaceuticals Private Limited, buy the company report.
Recent activity
Difgen Pharmaceuticals Private Limited has 20 board changes on record since 2022: 11 appointments and 9 cessations. The latest: Narasimhan Sridhar Nagaarjun was appointed as Additional Director on 13 Feb 2025.
AGM
Difgen Pharmaceuticals Private Limited last Annual general meeting of members was held on 11 Sep 2025 as per latest MCA records.
Filing
Difgen Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Narasimhan Sridhar Nagaarjun was appointed as Additional Director.
Appointed
Valiveti Brahmaji was appointed as Additional Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.27 Cr with Charge ID 100937260 was registered on 28 May 2024.
Ceased
Amol Ashok Walke ceased to be Additional Director.
Ceased
Krishna Chandrasekaran ceased to be Additional Director.
Ceased
Punit Chunilal Thakrar ceased to be Additional Director.
Ceased
Ramandeep Singh Jaj ceased to be Additional Director.
Ceased
Santhanakrishnan Srinivasan ceased to be Additional Director.
Ceased
Vijay Kumar Vasireddy ceased to be Additional Director.
Ceased
Yatin Kirtanlal Desai ceased to be Additional Director.
13 earlier events are in the company report.
Frequently asked questions
Difgen Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in the research and development industry. It was incorporated on 06 May 2022 (4+ years old) and is registered under CIN U72100TG2022PTC162383.
Difgen Pharmaceuticals has 11 current directors:
- Valiveti Brahmaji - Additional Director
- Krishna Chandrasekaran - Director
- Zubin Keki Gandhi - Director
- Yatin Kirtanlal Desai - Director
- Punit Chunilal Thakrar - Director
- Santhanakrishnan Srinivasan - Director
- Srinivasan Vedantham - Director
- Amol Ashok Walke - Director
- Vijay Kumar Vasireddy - Director
- Narasimhan Sridhar Nagaarjun - Additional Director
- Ramandeep Singh Jaj - Director
The latest financial statements of Difgen Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 11 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Difgen Pharmaceuticals is 36AAJCD2630H1ZT, registered in Telangana.
The CIN (Corporate Identification Number) of Difgen Pharmaceuticals is U72100TG2022PTC162383. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Difgen Pharmaceuticals was incorporated on 06 May 2022, making it 4+ years old. It is registered with the Registrar of Companies, Hyderabad.
Difgen Pharmaceuticals has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹99 Lakh; the latest was in July 2022.
Narasimhan Sridhar Nagaarjun was appointed as Additional Director on 13 Feb 2025. Valiveti Brahmaji was appointed as Additional Director on 21 Jan 2025. Amol Ashok Walke ceased to be Additional Director on 14 Nov 2023. Difgen Pharmaceuticals has 20 board changes on record in total.
Yes, Difgen Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Difgen Pharmaceuticals can be reached through the website difgen.com. Its registered office is in Hyderabad, Telangana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages